Do you feel hungry on Mounjaro — and is that normal?

What the SURMOUNT trial data tell us about appetite on tirzepatide

The clearest evidence comes from SURMOUNT-1, a 72-week trial of more than 2,500 adults with obesity published in the New England Journal of Medicine. Participants at the 15mg maintenance dose lost an average of around 20–21% of body weight. That scale of loss is almost entirely driven by a sustained drop in calorie intake, which only happens when appetite is genuinely suppressed over months, not days. Tirzepatide's dual mechanism is central to that: GLP-1 receptor activation slows the rate at which food leaves the stomach, while GIP receptor activation appears to reinforce satiety signalling in the brain. The result, for most people, is that meals feel filling much sooner, snacking urges quieten, and the mental preoccupation with food that many describe before treatment tends to ease.

The NHS medicines page for tirzepatide lists reduced appetite as an expected effect rather than a side effect, it is how the medicine achieves what it is prescribed for. That distinction is worth holding onto if you are in the early weeks and wondering whether the hunger reduction you experience is normal or too much.

Why you might still feel hungry on Mounjaro, the three most common patterns

Feeling hungry on Mounjaro does not automatically mean something is wrong. Three patterns account for most of what people notice.

The first is the starter-dose window. Treatment begins at 2.5mg, a dose calibrated to help your body adjust rather than to suppress appetite fully. The appetite-reducing effect builds with each titration step, so hunger at 2.5mg or 5mg does not tell you how you will feel at higher doses. Many people describe the shift becoming more pronounced somewhere between 5mg and 10mg.

The second pattern is end-of-week hunger. Because tirzepatide is injected once a week, plasma levels naturally dip before the next dose. Some people notice that hunger edges back in the 24–48 hours before injection day. This is a pharmacokinetic pattern rather than treatment failure, and it usually lessens as the body reaches steady state after several weeks. If you find it significant, it is worth raising at your clinical review, injection timing and dose adjustments are the right tools, not just willpower.

The third pattern is emotional or habitual hunger rather than physical hunger. Tirzepatide suppresses physiological appetite signals, but it does not rewire habits around boredom, stress or social eating. Some people find those cues feel stronger precisely because physical hunger is quieter. Recognising the difference helps. For guidance on what and when to eat during treatment, a practical starting point is our page on eating well on Mounjaro.

When persistent hunger on Mounjaro warrants a clinical conversation

If you feel hungry throughout the week at your current dose (not just in the run-up to injection day) that is clinically relevant information. It may indicate that titration to the next dose level is appropriate, or that something else is affecting how the medicine is working. Certain medicines, stress, disrupted sleep and under-eating (eating too little protein in particular) can all blunt the appetite effects. Some people also find that hunger returns more noticeably in periods of higher stress or illness.

There is a specific question worth separating out here: feeling hungry versus feeling that you need to eat when you are not actually hungry. Some people on Mounjaro notice that appetite suppression is strong enough that they are having to encourage themselves to eat enough, which brings its own questions around protein adequacy and energy intake. These are not the same problem and need different conversations.

Treatment is not static. Dose titration is built into how Mounjaro is used, and a prescriber reviews progress before each repeat prescription. If hunger is affecting how treatment is going for you, the clinical team is the right place to take it, not a forum, and not a decision to make alone. Our prescribers at nume's clinical team review every repeat order before it is dispensed, specifically to catch and address exactly these questions.

For a more detailed look at why hunger sometimes persists despite treatment being in place, the page on why you feel hungry on Mounjaro covers the mechanisms in more depth. And if your hunger has been consistently higher than you expected even at a maintenance dose, the still hungry on Mounjaro page addresses that specific situation directly.

One practical note: if your injection day happens to land on a bank holiday or you are travelling and your order arrives late, the dip in coverage before the next dose can feel more pronounced than usual. It is worth planning ahead so gaps do not compound the end-of-week pattern.

Mounjaro is a licensed UK prescription medicine for weight management in adults, available privately without a waiting list through a regulated online pharmacy. If you have questions about whether treatment is right for you, our prescribers offer a free consultation reviewed the same day.